{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 443778442
| IUPAC_name = 10-(2-Dimethylaminopropyl)-''N'',''N''-dimethylphenothiazine-2-sulfonamide
| image = Dimetotiazine.svg

<!--Clinical data-->
| tradename =
| Drugs.com = {{drugs.com|international|dimetotiazine}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = Rx-only
| routes_of_administration = [[Oral administration|By mouth]]

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 7456-24-8
| ATC_prefix = N02
| ATC_suffix = CX05
| ATC_supplemental =
| PubChem = 3089
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB08967  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 1FTA475ZDB
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07854
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 2979
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C19H25N3O2S2/c1-14(20(2)3)13-22-16-8-6-7-9-18(16)25-19-11-10-15(12-17(19)22)26(23,24)21(4)5/h6-12,14H,13H2,1-5H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = VWNWVCJGUMZDIU-UHFFFAOYSA-N

<!--Chemical data-->
| chemical_formula =  
| C=19 | H=25 | N=3 | O=2 | S=2 
| molecular_weight = 391.55 g/mol
| smiles = CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)S(=O)(=O)N(C)C)N(C)C
}}

'''Dimetotiazine''' ([[International Nonproprietary Name|INN]]) is a [[phenothiazine]] [[drug]] used for the treatment of [[migraine]]. It is a [[serotonin antagonist]] and [[histamine antagonist]].<ref>{{cite journal | last1 = Shimazawa | first1 = M | last2 = Hara | first2 = H | last3 = Watano | first3 = T | last4 = Sukamoto | first4 = T | title = Effects of Ca<sup>2+</sup> Channel Blockers on Cortical Hypoperfusion and Expression of c-Fos-Like Immunoreactivity After Cortical Spreading Depression in Rats | journal = British Journal of Pharmacology | date = August 1995 | volume = 115 | issue = 8 | pages = 1359â€“68 | doi = 10.1111/j.1476-5381.1995.tb16624.x | pmid = 8564192 | pmc = 1908864}}</ref>

==References==
{{reflist}}

{{Antimigraine preparations}}
{{Histaminergics}}
{{Serotonergics}}

[[Category:Antimigraine drugs]]
[[Category:H1 receptor antagonists]]
[[Category:Phenothiazines]]
[[Category:Serotonin antagonists]]
[[Category:Sulfonamides]]

{{analgesic-stub}}